← All news

FROM THE NEWS FEED

Compass Pathways partnering with national mental health clinic chain; Government lifts clinical hold on synthetic 5-MeO-DMT; and DEA ups drug quotas for psilocybin, psilocin, and DMT research

2026-01-09 • The Microdose (Berkeley)

Article summary

Plus: DEA extends telemedicine policy for yet another year and Qualitative experiences from a Compass psilocybin clinical trial

Continue to the original publication for the complete article.